𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of HIV-1 expression by HIV-2

✍ Scribed by J. Rappaport; M. W. Richardson; P. E. Klotman; S. K. Arya; G. Baier-Bitterlich


Publisher
Springer
Year
1995
Tongue
English
Weight
855 KB
Volume
73
Category
Article
ISSN
0946-2716

No coin nor oath required. For personal study only.

✦ Synopsis


HIV-1 and HIV-2 are co-endemic in certain geographic areas. HIV-2 is more weakly pathogenic than HIV-1, and progression to AIDS occurs less frequently and over a longer period of time. Recent epidemiologic studies suggest that individuals infected with HIV-2 have a lower risk of HIV-1 infection. Both immune mechanisms and various modes of viral interference have been proposed to account for these results. Our findings, described in this paper, suggest that HIV-2 inhibits HIV-1 replication. To study the molecular interactions between HIV-1 and HIV-2, proviral clones were transfected alone or in combination into the human T cell line CEM. LTR-CAT indicator constructs were included for the purpose of monitoring viral promoter activity. Viral replication in transfected cells was monitored by p24 antigen capture assay of cell culture supernatants and Western blot analysis of cell extracts. HIV-2 inhibited HIV-1 replication as determined by intracellular and extracellular p24 antigen levels. Similar results were obtained with simultaneous virus infection using HIV-1 and HIV-2, rather than transfections of proviral DNA. Using cotransfection of HIV-1 and HIV-2 LTR indicator gene constructs, the mechanism of inhibition was found to be suppression of the HIV-1 LTR by HIV-2. The inhibitory effect of HIV-2 is not due to Tat-2, but appears to discriminate between the HIV-1 and HIV-2 LTRs based on differences in the Tat activation response element, TAR. These results suggest both a molecular mechanism for HIV-2 interference with HIV-1 replication and a potential molecular approach to therapy.


πŸ“œ SIMILAR VOLUMES


Expression of HIV-1 integrase in CEM cel
✍ Johan van Griensven; Xiaojing Zhan; BΓ©nΓ©dicte Van Maele; Wim Pluymers; Martine M πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 247 KB

## Abstract ## Background HIV‐1 integrase (IN) is an interesting target for the gene therapy of AIDS. Although the __in vivo__ functions are not well characterized, it is thought that IN has pleiotropic effects and plays a central role in the interplay between the virus and the host cell. Expressi

Inhibition of SNAP25 expression by HIV-1
✍ Davide Eletto; Giuseppe Russo; Giovanni Passiatore; Luis Del Valle; Antonio Gior πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 498 KB

## Abstract MicroRNAs (miRs) are short endogenous RNAs that regulate gene expression by incomplete pairing with messenger RNAs. An increasing number of studies show that mammalian microRNAs play fundamental roles in various aspects of cellular function including differentiation, proliferation, and

Upregulation of HTLV-1 and HTLV-2 expres
✍ Upal Roy; Scott A. Simpson; Debasis Mondal; Sandra Eloby-Childress; Elsa L. Wins πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 186 KB

## Abstract Co‐infections with HIV‐1 and the human T leukemia virus types 1 and 2 (HTLV‐1, HTLV‐2) occur frequently, particularly in large metropolitan areas where injection drug use is a shared mode of transmission. Recent evidence suggests that HIV‐HTLV co‐infections are associated with upregulat

Inhibition of HIV protease by monoclonal
✍ P. Rezacova; J. Brynda; M. Fabry; M. Horejsi; R. Stouracova; J. Lescar; V. Chita πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 272 KB

## Abstract The protease of HIV plays a critical role in the maturation of the infectious particles of the virus. The enzyme has therefore been extensively studied with the objective of developing therapeutics that inhibit viral proliferation. We have produced monoclonal antibodies specific for the